English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/175334
logo share SHARE   Add this article to your Mendeley library MendeleyBASE
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE
Exportar a otros formatos:


Fatty acid amides for the prevention and/or treatment of steatohepatitis

AuthorsRodríguez de Fonseca, Fernando; Pavón Morón, Francico Javier; Serrano Criado, Antonia; Decara del Olmo, Juan Manuel; Joglar Tamargo, Jesús ; Clapés Saborit, Pere ; Torre, Rafael de la; Ferre Albaladejo, Magí; Covas, María Isabel; Fitó, Montserrat; Almeida Cotrim, Bruno
Issue Date4-Oct-2017
CitationEP3225237 A1
AbstractThe invention relates to the use of fatty acid amides with phenylalkylamines and a pharmaceutical composition comprising at least one of said compounds in the prevention and/or treatment of fatty liver or a pathological condition or disease caused by fatty liver, either alcoholic or non-alcoholic, and in particular, for the prevention and/or treatment of alcoholic steatohepatitis or non-alcoholic steatohepatitis (NASH).
Appears in Collections:(IQAC) Patentes
Files in This Item:
File Description SizeFormat 
EP3225237A1.pdf3,31 MBAdobe PDFThumbnail
Show full item record
Review this work

WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.